5-羟基噻苯咪唑结构式
|
常用名 | 5-羟基噻苯咪唑 | 英文名 | 5-hydroxy Thiabendazole |
|---|---|---|---|---|
| CAS号 | 948-71-0 | 分子量 | 217.25 | |
| 密度 | 1.535g/cm3 | 沸点 | 525.6ºC at 760mmHg | |
| 分子式 | C10H7N3OS | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | 271.7ºC | |
| 符号 |
GHS07, GHS09 |
信号词 | Warning |
5-羟基噻苯咪唑用途5-Hydroxythiabendazole(5-OHTBZ)是 Thiabendazole(HY-B0263)暴露的生物标志物。 |
| 中文名 | 噻苯咪唑-5-羟基 |
|---|---|
| 英文名 | 5-Hydroxy Thiabendazole |
| 中文别名 | 5-羟基噻苯咪唑 |
| 英文别名 | 更多 |
| 描述 | 5-Hydroxythiabendazole(5-OHTBZ)是 Thiabendazole(HY-B0263)暴露的生物标志物。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 1.535g/cm3 |
|---|---|
| 沸点 | 525.6ºC at 760mmHg |
| 分子式 | C10H7N3OS |
| 分子量 | 217.25 |
| 闪点 | 271.7ºC |
| 精确质量 | 217.03100 |
| PSA | 90.04000 |
| LogP | 2.39200 |
| InChIKey | VNENJHUOPQAPAT-UHFFFAOYSA-N |
| SMILES | Oc1ccc2nc(-c3cscn3)[nH]c2c1 |
| 折射率 | 1.783 |
| 储存条件 | 0-6°C |
|
~%
5-羟基噻苯咪唑 948-71-0 |
| 文献:Xenobiotica, , vol. 26, # 7 p. 765 - 778 |
| 5-羟基噻苯咪唑上游产品 1 | |
|---|---|
| 5-羟基噻苯咪唑下游产品 1 | |
| 海关编码 | 2934999090 |
|---|---|
| 中文概述 | 2934999090. 其他杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途 |
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Multi-residue Determination of Polar Veterinary Drugs in Livestock and Fishery Products by Liquid Chromatography/Tandem Mass Spectrometry.
J. AOAC Int. 98(1) , 230-47, (2015) Residues of 37 polar veterinary drugs belonging to six families (quinolones, tetracyclines, macrolides, lincosamides, sulfonamides, and others) in livestock and fishery products were determined using ... |
|
|
Evidence for cytochrome P4501A2-mediated protein covalent binding of thiabendazole and for its passive intestinal transport: use of human and rabbit derived cells.
Chem. Biol. Interact. 127(2) , 109-24, (2000) Thiabendazole (TBZ), an anthelmintic and fungicide benzimidazole, was recently demonstrated to be extensively metabolized by cytochrome P450 (CYP) 1A2 in man and rabbit, yielding 5-hydroxythiabendazol... |
|
|
In vitro and in silico identification and characterization of thiabendazole as a mechanism-based inhibitor of CYP1A2 and simulation of possible pharmacokinetic drug-drug interactions.
Drug Metab. Dispos. 37 , 1286-1294, (2009) Thiabendazole (TBZ) and its major metabolite 5-hydroxythiabendazole (5OH-TBZ) were screened for potential time-dependent inhibition (TDI) against CYP1A2. Screen assays were carried out in the absence ... |
| 2-(1,3-thiazol-4-yl)-3H-benzimidazol-5-ol |